Literature DB >> 8829220

Xanthine oxidase/dehydrogenase is present in human placenta.

A Many1, A Westerhausen-Larson, A Kanbour-Shakir, J M Roberts.   

Abstract

Xanthine dehydrogenase/oxidase (XDH, EC 1.1.1.204, XO, EC 1.2.3.2) produces uric acid, and in the oxidase form also generates the free radical superoxide. Previous reports failed to demonstrate XDH/XO activity in human placenta. Our objective was to determine evidence of XDH/XO in human placenta. We developed a cDNA probe for human XDH/XO and used it to detect mRNA by Northern hybridization. Immunohistochemical localization of the enzyme in placental tissue was performed using a specific antibody for XDH/XO and ABC-peroxidase. Enzyme activity assay was determined by the conversion of [14C] xanthine to [14C] uric acid. mRNA was detected in all placental samples (n = 4). Villous and non-villous trophoblast cells expressed immunohistochemical staining for XOD (n = 4). Enzyme activity was detected in all placentae (n = 6). Despite previous reports, we found mRNA, XDH/XO protein and enzyme activity in human placenta localized to trophoblast cells. Enzyme activity was much lower than in liver. Several conditions in the maternal-fetal unit could potentially increase XDH/XO activity and conversion of the enzyme to its oxidase form.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8829220     DOI: 10.1016/s0143-4004(96)90061-2

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  8 in total

1.  In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies.

Authors:  T H Hung; J N Skepper; G J Burton
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia.

Authors:  A Many; C A Hubel; S J Fisher; J M Roberts; Y Zhou
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 3.  Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta.

Authors:  L Myatt
Journal:  Placenta       Date:  2010-01-27       Impact factor: 3.481

Review 4.  Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Authors:  Ankit Balhara; Aditya R Kumar; Jashvant D Unadkat
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

Review 5.  Oxidative stress in the placenta.

Authors:  Leslie Myatt; Xiaolan Cui
Journal:  Histochem Cell Biol       Date:  2004-07-10       Impact factor: 4.304

6.  Chocolate consumption in pregnancy and reduced likelihood of preeclampsia.

Authors:  Elizabeth W Triche; Laura M Grosso; Kathleen Belanger; Amy S Darefsky; Neal L Benowitz; Michael B Bracken
Journal:  Epidemiology       Date:  2008-05       Impact factor: 4.822

Review 7.  Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review).

Authors:  Adriana V Treuer; Daniel R Gonzalez
Journal:  Mol Med Rep       Date:  2014-11-18       Impact factor: 2.952

8.  Hypoxia and oxidative stress induce sterile placental inflammation in vitro.

Authors:  Bernadette C Baker; Alexander E P Heazell; Colin Sibley; Rachael Wright; Helen Bischof; Frances Beards; Tatiana Guevara; Sylvie Girard; Rebecca L Jones
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.